# Outcome of ADPKD With Octreotide LAR

> **NCT06193616** · — · ACTIVE_NOT_RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 70 (estimated)

## Conditions studied

- Autosomal Dominant Polycystic Kidney

## Interventions

- **DRUG:** Octreotide

## Key facts

- **NCT ID:** NCT06193616
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-12
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06193616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06193616, "Outcome of ADPKD With Octreotide LAR". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06193616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*